Ocata Therapeutics, Inc. (NASDAQ: OCAT) today announced that it continues to fortify the scope of protection covering its retinal pigment ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE